Content |
Assets | Owners |
+ Bioniq Health-tech Solutions |
Bioniq was founded in early 2019 by former German national basketball player Vadim Fedotov and scientist and neurosurgeon Konstantin Karuzin, who spent more than 14 years conducting clinical trials of pharmacological drugs and technologies in Switzerland and Russia for companies such as GlaxoSmithKline and Pfizer.
History
2022: Bioniq acquires German fitness start-up Vaha for €150m
On December 7, 2022, it became known about the sale of 100% Vaha to British to the vitamin manufacturer the Russian with the founders of Bioniq. The company did not disclose the fiance terms of the agreement. More. here
2021: Raising $15 million in investments
On January 13, 2021, it became known that Bioniq had attracted about $15 million in investments. Almost half of this amount - $7.2 million - was provided by AFK Sistema. In addition, the Luxembourg venture capital fund OKS Group invested in the developer of telemedicine services with the participation of a number of other investors (together they provided $7.8 million).
As clarifies Kommersant"," AFK Sistema invested in the Russian subsidiary of the British company Bioniq. The funds raised startup intend to spend on expanding DNA testing services and developing tools for maintaining psychological health. According to the chairman of the board of directors of the Russian subsidiary Bioniq, the Vadim Fedotova company will use the funds received to develop a project on DNA tests of its own development.
In addition, with the funding raised, Bioniq will complement the product line with personalized menus and tools to maintain psychological health. The growth of the company in the Russian medical services market is ensured by a partnership with a network of private clinics Medsi"," which is part of AFK Sistema, Fedotov said.
According to the GritDaily portal, the company focused on the Russian market thanks to cooperation with Medsi, but at the same time it intends to develop business in other countries. Axios, citing Bioniq, writes that an investment round A Series was held, and the money raised is planned to be spent on expanding the company's business in the United States and the Middle East.[1][2][3]
2020: Creation of Bayonic-Medsi
At the end of February 2020, Medsi and Bioniq Health-tech Solutions announced the creation of the Bayonic-Medsi enterprise, within which the companies will develop a digital personalized system for monitoring and promoting public health. The new business will be headed by Vadim Fedotov, founder of the international company Bioniq Health-tech Solutions, formerly CEO of Gazprom-Media Technologies. Read more here.
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |